TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
DNA Development i Stockholm AB
Closing information (x1000 NOK)
| Closing information | 2025/08 | 2024/08 | 2023/08 |
| Turnover |
1,089
|
1,275
|
1,692 |
| Financial expenses |
0
|
4
|
114 |
| Earnings before taxes |
-112
|
-14
|
273 |
| EBITDA |
-123
|
-28
|
272 |
| Total assets |
1,687
|
2,100
|
2,485 |
| Current assets |
625
|
1,071
|
1,510 |
| Current liabilities |
40
|
105
|
238 |
| Equity capital |
1,552
|
1,886
|
2,144 |
| - share capital |
53
|
51
|
49 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Solvency |
92.0%
|
89.8%
|
86.3% |
| Turnover per employee |
1,089
|
1,275
|
1,692 |
| Profit as a percentage of turnover |
-10.3%
|
-1.1%
|
16.1% |
| Return on assets (ROA) |
-6.6%
|
-0.5%
|
15.6% |
| Current ratio |
1562.5%
|
1020.0%
|
634.5% |
| Return on equity (ROE) |
-7.2%
|
-0.7%
|
12.7% |
| Change turnover |
-227
|
-510
|
-768 |
| Change turnover % |
-17%
|
-29%
|
-31% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.